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The epithelial Naþ/Hþ exchanger-3 (NHE3) activity is pivotal in maintaining
renal and intestinal sodium homeostasis. NHE3 activity is regulated by a variety
of hormonal stimuli and is dysregulated in severe disorders such as hypertension,
heart failure, acute kidney injury, diabetic nephropathy and diarrhea. NHE3 ex-
ists as monomers and oligomers; though, the requirement of dynamic change in
NHE3 stoichiometry for its regulation has not been established. Extra- and intra-
cellular tagged NHE3 was expressed on cell membrane of live cells in form of
monomers and oligomers (ratiomonomer : oligomer, ~1:1) detected by Total In-
ternal Reflection Fluorescence (TIRF) and Fo¨rster Resonance Energy Transfer.
The oligomers had slower lateral mobility compared to monomers (determined
by TIRF and Fluorescence Recovery After Photobleaching). Activation or inhi-
bition of NHE3 transport by well-characterized stimuli induced a significant
shift in the monomer : oligomer ratio toward formation of NHE3 oligomers
(~1:2 and~1:1.5, respectively) and reduction inNHE3 lateralmobility. Blocking
NHE3 binding to the calcium binding protein, the Calcineurin Homologous Pro-
tein-1 (CHP1), by a cell-penetrating peptide from CHP1 binding region
(competing for CHP1 binding to NHE3) increased the number of NHE3 oligo-
mers (~1:2). In summary, a dynamic change in the NHE3 monomer : oligomer
ratio toward an increase in NHE3 oligomers is proposed as the molecular signal
necessary for stimuli-mediated NHE3 regulation. It is proposed that oligomeri-
zation is an essential step in the regulation of NHE3 activity and that changes in
NHE3 monomer : oligomer ratio are under control of CHP1 binding to NHE3.
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Endosomal dysfunction has been implicated as an early step in neurodegenera-
tion. Endosomes are amajor site of production ofAb peptide from the processing
of amyloid precursor protein (APP) by clipping enzymes (b and g-secretases).
The b-secretase enzyme BACE-1 requires acidic lumen pH for optimum func-
tion and acid pH promotes Ab aggregation. The endosomal Naþ/Hþ exchanger
NHE6provides a leak pathway for protons, limiting luminal acidification by pro-
ton pumps. Therefore, we investigated whether NHE6 expression altered APP
localization and processing in a stably transfected cell culture model of human
APP expression. We show that co-expression with NHE6 shifts APP away
from trans Golgi network into early and recycling endosomes in HEK293 cells.
NHE6 alkalinized the endosomal lumen and significantly attenuated APP pro-
cessing and Ab secretion. To rule out non-specific overexpression effects we
examined the effects of NHE6 mutations associated with neurodegeneration,
whichwepredicted to result in loss of function bymapping on to the three dimen-
sional homologymodel of NHE6 generated based on the template structure of E.
coli NhaA. Finally, we show that NHE6 transcript and protein levels are lowered
in post-mortem Alzheimer’s brains relative to age-matched control brains. Pa-
tients with mutations in NHE6 show progressive neurodegeneration and tau pa-
thologies. These observations, taken together with emerging evidence from
genome wide association studies, suggest that endosomal Naþ/Hþ exchangers
act as proton leak pathways that regulate Ab generation and contribute to disease
etiology. We suggest that therapeutic elevation of endosomal pH using mildly
alkalinizing drugs or by enhancing NHE6 activity will significantly reduce am-
yloid and tau pathologies.
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Membrane transport proteins play a central role in many biological processes
by mediating the transport of many different solutes, such as ions, nutrients,
and neurotransmitters across biological membranes. Numerous pathological
conditions result from impairments in the function of molecules of this class.
Many prokaryotic and eukaryotic Naþ-driven transporters couple the move-
ment of one or more Naþ ions down their electrochemical gradient to the active
transport of a variety of solutes. When more than one Naþ is involved, Naþ
binding data are usually analyzed using the Hill equation with a non-integer
exponent n. The results of this analysis are an overall Kd-like constant and n,
a measure of cooperativity. This information is usually insufficient to provide
the basis for mechanistic models. In the case of transport utilizing two Naþ ions
n< 2 indicates that molecules with only one of the two sites occupied is present
at low saturation. Here we propose a new way of analyzing Naþ binding data
for the case of two Naþ ions that, by taking into account binding to individual
sites, yields bounded ranges of pairs of possible values for the Naþ affinities of
the individual sites. These values provide far more information than can be ob-
tained by using the Hill equation with a non-integer coefficient.
To illustrate the advantages of the new analysis we used experimental data on
Naþ binding to the Naþ/I- symporter (NIS)—the key protein that mediates the
first step for the biosynthesis of the thyroid hormones—obtained by scintilla-
tion proximity assay (SPA). The same formalism can be used to analyze data
of other proteins that bind the same substrate at two binding sites.
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Transport of cholesterol intomitochondria is the first and rate limiting step of ste-
roid hormone synthesis. Translocator protein 18 kDa (TSPO) is recognized as a
key player in this process and is highly expressed in steroidogenic tissues, met-
astatic cancer, Alzheimer’s and Parkinson’s diseases, and inflammatory condi-
tions. TSPO ligands have been shown to influence apoptosis and cancer cell
migration, and are widely used in PET imaging. However, conflicting data
and lack of high resolution structures have led to much controversy concerning
the precise role of this conserved, developmentally-required protein. To better
understand the mechanism of cholesterol transport and its regulation by various
ligands, we utilized the purified TSPO from Rhodobacter sphaeroides
(RsTSPO), a bacterial homolog that shares a conserved function with the
mammalian protein, to investigate the properties of TSPO biochemically and
crystallographically. We determined high resolution crystal structures of
RsTSPOwild-type and a mutant equivalent to the bipolar disease-associated hu-
man single polymorphism (A147T) which has reduced pregnenolone produc-
tion. The crystal structures of RsTSPO provide new insight into ligand
interaction sites and alterations caused by the human polymorphism. A three
amino acid sequence adjacent to the cholesterol recognition consensus sequence
(CRAC) and theA147T sitewas identified by biochemical,mutational and struc-
tural studies as a cholesterol binding enhancement motif. Mutation to the human
sequence increases the binding of cholesterol by>1000 fold and an alkyl tail is
observed to bind in this site. The enhancement motif was also identified as
critical to the stability and function of TSPO by evolutionary co-variance
analysis. This motif was found in other human membrane proteins from several
major families, suggesting a general role in cholesterol binding. (NIH
R01GM26916, MSU Center for Mitochondrial Science and Medicine, SF-M)
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Sodium iodide symporter (NIS) is a membrane protein responsible for accumu-
lation of iodide (I-) in the thyroid and other organs. This is accomplished
through active transports in which the sodium (Naþ) gradient provides the
driving force. In our approach we attempt to bring together the most recent
finding on the NIS homologous systems and shine light on current and future
application of NIS in clinical treatment of thyroid cancer. Furthermore we
discuss our findings on NIS structure/function properties. The stoichiometry
of the transport event has been elusive and intensely debated. In our approach
we started with homology modeling to develop the NIS model. The structure
was based on the x-ray structure of Vibrio parahaemolyticus sodium/galactose
Monday, February 9, 2015 309asymporter (vSGLT), a close structural homologue exhibiting the same topolog-
ical fold. Based on the topological identity we also used the x-ray structure of
Aquifex aeolicus leucine transporter (LeuT) to further improve the model of
our system. Sequence alignment was performed to identify important residues
and potential substrate/ion binding sites. Radioactive labeled biomarkers were
used as potential substrates/inhibitors, in line with the clinical applications.
Aside from the radio-labeled iodide, we considered tetrafluoroborate, perchlo-
rate, bromide, and thiocyanate. Firstly, the binding sites were identified through
a docking process. Following which in order to enhance I- and inhibitor trans-
port, necessary for improved imaging, we had to expand our system beyond the
wild-type protein. The mutants we considered are all essential for transport and
they are Q72N, I147C, E368A, and M68A. By inducing different rates of trans-
port we can deduce how the protein responds to specific mutants. We have suc-
cessfully identified a favorable response to our mutations and we are hopeful
our approach to the engineered NIS protein will further aid in the treatment
and imaging of thyroidal and extrathyroidal cancers.
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The Naþ/I- symporter (NIS) mediates iodide transport into the thyroid and
other tissues, such as salivary glands, stomach, lactating breast, and small intes-
tine. To understand the observed effects of single amino acid substitutions in
the mechanism of transport by NIS, wild type NIS and NIS mutated at selected
positions were studied using computational methods. Normal modes analysis
with the Anisotropic Network Model (ANM) was used to explore the changes
in global movements between NIS and the mutants in the presence or absence
of the ions they transport (Naþ, I-, and ClO4-). ANM has been shown to be a
useful computational tool for predicting the dynamics of membrane proteins in
many applications. The lowest normal modes generated by the ANM provide
valuable insight into the global dynamics of biomolecules that are relevant to
their function. We employed a modified version of ANM in which closeness
of side chains are also used to assign alpha-carbons connections, allowing us
to identify differences due to mutations and the influence of ions on these global
movements, thus enabling a first approximation to the influence of mutations on
the transport mechanism of NIS.
To address questions relating to the coordination of the transported ions in the
wild type and in mutants, we carried out molecular dynamics simulations in a
lipid bilayer using an implicit solvent model with GBMV (Generalized Born
Molecular Volume) in both wild-type NIS and NIS mutants and their ions. A
homology model of NIS based on the structure of the bacterial homologue
vSGLT (Vibrio parahaemolyticus Naþ/galactose transporter) was used in
both the normal modes analysis and the molecular dynamics simulations.
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NhaA is a secondary active transporter that regulates the cellular concentrations
of proton and sodium ions. Sodium binding to two conserved aspartates Asp163
and Asp164 is thought to induce a conformational change from the inward- to
the outward-facing state. The dimeric crystal structure of E. coli NhaA in the
inward-facing state at acidic pH was recently determined. In contrast to the pre-
vious monomeric crystal structure, a salt bridge between the conserved residues
Asp163 and Lys300 is formed, while the transmembrane helix that contains
Lys300 is disrupted. To delineate the mechanism implicated by the structures,
we calculate the pKa values of Asp163, Asp164 and Lys300 using all-atom
continuous constant pH molecular dynamics simulations with pH-based
replica-exchange sampling protocol. The results provide new insights into
the working of the antiporter NhaA.
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USA.Lactose permease (LacY) has become a model system for monitoring substrate
transport across the lipid bilayer. As a result of considerable experimental and
structural data, the underlying molecular determinants for substrate specificity
and affinity, as well as a mechanism for symport have been postulated. We have
now monitored LacY structural dynamics in a lipid environment for 10 micro-
seconds by using molecular dynamics simulations of a recent mutant LacY
crystal structure trapped in a novel occluded state with bound high-affinity sub-
strate. On this timescale, the sugar molecule exits the protein and re-enters.
Therefore, the accompanying dynamics provide important clues regarding sub-
strate specificity. In particular, Phe27 and neighboring lipid molecules assist in
directing the sugar molecule to its binding position. In addition, simulations of
substrates with different binding affinities enabled characterization of the struc-
tural framework governing substrate affinity in LacY.
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The plethora of X-ray crystal structures in the Major Facilitator Superfamily
has provided a series of snapshots that define the alternating access mechanism
for ligand transport. A sticking point, however, is that there is not yet a series of
conformational states obtained from one organism to support the proposed
mechanism of transport. This is a problem that Molecular Dynamics (MD), us-
ing atomistic simulation, is ideally suited for to help improve the overall work-
ing hypotheses of how conformational changes in transmembrane helices occur
during ligand transport.
FucP is the only X-ray crystal structure in an outward facing conformation and
it is a L-fucose/Hþ symporter, much like LacY. The resting state for this pro-
tein is thought to be accessible to the periplasm (outward facing) and the pro-
tonation of E135 in the central, solvent-accessible cavity along with the binding
of the transported ligand, L-fucose is what destabilises the conformation,
causing a movement to the inward-open state, allowing ligand transport into
the cytoplasm.
Using MD simulation, the conformational changes FucP undergoes on ligand
binding can be characterised and related to the specific roles of each of the
12 transmembrane helices. In particular helices 1 and 4 are believed to be
pivotal to proton translocation via residues D46 and E135 [1], with E135
also involved in L-fucose binding. On protonation, the interaction between
E135 and Y365 (helix 10) is destabilised and this is investigated using both
biased and unbiased MD simulations to better define the degree to which the
protein is ‘open’.
1. Dang, S. et al., Structure of a fucose transporter in an outward-open confor-
mation, (2010), Nature, 467, 734-738.
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Folate cofactors play crucial roles in hundreds of reactions in cells includingDNA
and protein synthesis. The human proton-coupled folate transporter (PCFT) is the
onlymeansof absorptionof dietary folates in humans. PCFTexpression and func-
tion is associated with many disorders including hereditary folate malabsorption,
neural tube defects, Down syndrome, cancer, heart diseases, Alzheimer’s and
Parkinson’s disease. Upregulation of PCFT expression in tumor cells is of signif-
icant consideration for development of PCFT-targeted chemotherapeutic agents.
However, not much is known about the structure and function of PCFT, which
contributes to the low clinical success rate of folate-based agents. To address
this gap in the knowledge we performed extensive Cys-mutagenesis studies.
We analyzed 40 residues towards the extracellular face of PCFT, 35 positions to-
wards the cytoplasmic face of PCFT and 28 positions along the proposed folate-
binding pocket of PCFT. Based on the accessibility studies of the extracellular
face of PCFT we determined loop-helix boundaries of this face and identified
the glycerol-3-phosphate transporter (PDB#1PW4) and tripeptide-proton sym-
porter (PDB#4APS) as the best templates for modeling PCFT. Based on the
accessibility studies of the cytoplasmic face of PCFT, we identified loop-helix
boundaries of this face. Here, we also show that our accessibility studies support
the hypothesis that PCFT is present predominantly in an inward-open conforma-
tion in the absence of substrate (pH 7.5 and no folic acid). We also show that the
folate-binding pocket of PCFT is formed by residues present in PCFT transmem-
branehelices I, IV,V,XandXI.Our results areof high significance in understand-
ing the details of folate-homeostasis mechanisms and in design of PCFT-targeted
therapeutic and diagnostic agents.
